We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Faces Delay in Emergency Use Filing for its COVID-19 Vaccine
AstraZeneca Faces Delay in Emergency Use Filing for its COVID-19 Vaccine
AstraZeneca (AZ) reportedly may not file for FDA Emergency Use Authorization (EUA) of its COVID-19 vaccine until mid-May as it needs more time to gather supporting data.